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Abstract To investigate the regulatory DNA sequences re- 
quired for insulin-stimulation of the ATP citrate-lyase (ACL) 
gene as well as for polyunsaturated fatty acid (PUFA)- 
suppression of this gene, primary cultured hepatocytes were 
transfected with plasmids containing the 5'-flanking sequence of 
the rat ACL gene fused to the chloramphenicol acetyltransferase 
(CAT) gene. Sequences from -861,  -194 or -104  to +128 of 
the ACL gene directed an increase in CAT activity in 
hepatocytes when insulin was added to the medium containing 
either glucose or pyruvate. The CAT activities stimulated by 
insulin were reduced by the addition of PUFA, in accordance 
with the responses on the endogenous ACL gene expression. 
Further deletion to -20,  however, resulted in loss of the 
responses. The results suggest that the region from -104 to 
-20  of the ACL gene is responsible for regulation due to insulin 
and PUFAs. In particular, the region from -61  to -49  of the 
ACL has sequence similarity to the insulin-responsive r gions of 
fatty acid synthase and acetyi-CoA carboxylase. 
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I. Introduction 
ATP-citrate lyase (ACL) (EC 4.1.3.8) catalyzes the forma- 
tion of acetyl-CoA and oxaloacetate from citrate and CoA 
with a concomitant hydrolysis of ATP  to ADP and phos- 
phate. The product, acetyl-CoA serves several important bio- 
synthesis pathways, including lipogenesis and cholesterogen- 
esis. Thus, ACL  is considered as one of lipogenic enzymes. 
We previously reported that the gene expression of ACL in 
rat liver was increased by a fat-free/high-carbohydrate diet 
and decreased by fat-feeding or in fasted and diabetic states, 
in a similar manner  to other lipogenic enzymes [1,2]. The gene 
expression was primarily regulated at transcriptional step [1]. 
A l though transfection analyses using primary cultured he- 
patocytes demonstrated the presence of insulin-regulated cis- 
acting elements of fatty acid synthase gene [3,4], the insulin 
response lement has not been found in ACL gene. Moreover, 
the presence of PUFA-regulated c/s-acting elements has been 
reported in the proximal promotor  regions of genes of L-type 
pyruvate kinase and S14, which gene expression is coordi- 
nately regulated with lipogenic enzymes by nutrit ional and 
hormonal  manipulat ion [5,6]. However, little is known about 
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the DNA sequences involved in expression of ACL. In order 
to investigate ACL gene expression, transfection system using 
cultured primary hepatocytes of rats was utilized in the pre- 
sent study. 
2. Materials and methods 
2.1. Materials" 
Restriction endonucleases and other enzymes were purchased from 
Takara Shuzo. The sequence kit, luciferase assay kit and acetyl-CoA 
were from Applied Biosystems, Toyo Ink and Sigma, respectively. 
Williams' medium E was purchased from Flow Laboratories. Other 
culture media were obtained from Nissui Seiyaku. 
[llC]Chloramphenicol (2.22 GBq/mmol) and [c~-3~P]dCTP (111 TBql 
mmol) were from ICN. Lipofectin reagent was from Life Technolo- 
gies. 
2.2. Plasmid constructs 
Plasmid pUC0cat, a promoter-less CAT vector, and pUC2cat, a 
CAT vector with simian virus 40 early enhancer and promotor were 
used as negative and positive controls, respectively [7]. Plasmid pactL, 
a luciferase vector containing [3-actin enhancer and promoter, was 
used as an internal control to normalize for variations in transfection 
efficiency [8]. 
An ACL genomic clone was obtained by screening rat EMBL3 
genomic library (Clontech) with rat ACL cDNA [1]. We sequenced 
the region from -2394 to +128 of this gene and found that sequences 
of this region coincided with those reported by Kim et al. [9]. ACL- 
cat2394 was constructed by ligating a XhoI/HindIII fragment (-2394 
to +128) of the rat ACL gene into SalIlHindlIl site of puC0cat. 
Deletion of the ACLcat2394 plasmid was carried out using an exo- 
nuclease III. The fragments obtained were ACLcat2268, ACLcatI945, 
ACLcat1780, ACLcatl517, ACLcat1375, ACLcatl081, ACLcat861, 
ACLcat537, ACLcat194, ACLcatl04 and ACLcat20. These CAT con- 
structs have 3' endpoint at +128 and 5' endpoint at -2268, -1945, 
-1780, 1517, -1375, -1081, -861, -537, -194, -104 and -20, 
respectively, relative to the transcription start site of the rat ACL 
gene. The sequence of these inserts was verified by dideoxy sequen- 
cing, using a sequenase kit [10]. 
2.3. Primary hepatocyte culture and transJection 
Male Wistar rats (200 250 g) maintained on a stock diet (Oriental 
Koubo, MF) were fasted for 16 h before experiments. The hepato- 
cytes were isolated by the collagenase perfusion method [11,12] and 
plated at a density of 3 x 10 6 cells/60 mm Primaria culture dish (Fal- 
con). After a 6 h attachment period, medium was replaced with mod- 
ified Williams' E media (lacking methyl inolate) supplemented with 5 
mM glucose, 26 mM sodium bicarbonate, 2 mM glutamine and 1 laM 
dexamethasone, and then mixtures of 2 gg of pactL and 18 lag each of 
CAT constructs were transfected into hepatocytes u ing lipofectin for 
16 h. Subsequently, cells were cultured for 48 h in experimental media 
(with 100 lag/ml streptomycin and 100 U/ml penicillin) containing 
either 20 mM glucose or pyruvate with or without 0.1 laM insulin. 
When included, 0.1 mM fatty acids was added. All transfections were 
performed at least twice. 
2.4. CA T and luciferase assay 
The cells were incubated for 48 h after transfection, harvested and 
lysed by sonication. Then 20 lal of the supernatant from each sample 
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were assayed for luciferase [13] using a kit. Normalized amounts of 
the cell extracts by luciferase activity were used for CAT assays after 
heating at 60°C for 10 min [14,15]. Acetylated and nonacetylated 
forms of [t4C]chloramphenicol were determined by scintillation coun- 
ter and the percentages of the acetylated forms were calculated. All 
transfections were performed at least three times in duplicate. 
2.5. Preparation of RNA and dot blot hybridization assay 
Total cellular RNA was isolated from cultured cells by the method 
of acid guanidine thiocyanate-phenol-chloroform extraction [16]. The 
cDNA species of ACL were cloned as described previously [1]. The 
genomic lone of rat rRNA was obtained from Japanese Cancer Re- 
search Resources Bank (Tokyo, Japan). About 1 kb BamHIIEcoRI 
fragment of this clone was isolated and used as a probe for 18S 
rRNA. The cDNAs were labeled by a multiprimer DNA labeling 
system kit (Amersham, Buckinghamshire, UK) using [ot-a2p]dCTP. 
To measure the mRNA concentration of the enzyme, the total 
RNA (20 l.tg) was denatured with formaldehyde at 65°C for 15 min, 
spotted on nylon filter, and then radiated with UV light for 5 min, 
The filter was prehybridized and then hybridized as described pre- 
viously [17]. Relative densities of the hybridization signals were deter- 
mined by scanning the autoradiograms at 525 nm and normalized to 
the values of the 18S rRNA. 
3. Results and discussion 
3.1. Effects of insulin and PUFA on ACL mRNA concentration 
in cultured hepatocytes 
We previously found that the mRNA inductions of lipo- 
genic enzymes became maximum after 1624 h in cultured 
hepatocytes of rat and the maximum levels still continued 
after 48 h [18]. Therefore, to examine the effects of insulin, 
glucose and PUFA on the endogenous ACL gene expression, 
the mRNA concentrat ions were measured after 48 h incuba- 
tion of hepatocytes. As shown in Table 1, the addit ion of 
insulin clearly enhanced the mRNA concentrat ions of ACL 
in the presence of pyruvate or glucose, indicating that glucose 
is not necessarily required for the effect of insulin on this gene. 
The insulin st imulation was markedly suppressed by arachi- 
donic acid (20:4). 
3.2. Insulin and PUFA regulation of transfected ACL gene 
To define the ability of ACL sequences to direct insulin- 
stimulated expression, the constructs between -2394 and 
+128 of the ACL  gene were fused to the CAT gene and in- 
troduced into pr imary hepatocytes. The cells were cultured in 
the presence of 20 mM pyruvate or glucose with or without 
Table l 
Effects of insulin and PUFA on ACL mRNA concentrations in cul- 
tured hepatocytes 
Additions mRNA concentration 
(-fold) 
Pyruvate 0.50 + 0.10 
Pyruvate+insulin 1.47 + 0.27 
Pyruvate+insulin+20: 4 0.55 + 0.12 
Glucose 0.50 + 0.13 
Glucose+insulin 1.00 
Glucose+insulin+20: 4 0.43 _+ 0.12 
After 16 h preculture without serum and hormones in 5 mM glucose, 
hepatocytes were incubated with or without 0.1 ~M insulin for 48 h in 
the presence of 20 mM pyruvate or glucose. When included, 0.1 mM 
arachidonic acid (20:4, n-6) was added. The mRNA concentrations 
were normalized to the value glucose + insulin. Meari + S.D. (n = 5~). 
Table 2 
Expression of ACLcat fusion genes in rat hepatocytes 
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Relative CAT activity 
(%) 
ACLcat2394 99.6 _+ 21.8 
ACLcat2268 83.7 + 15.9 
ACLcat1945 108 + 33.5 
ACLcat1780 93.7 + 34.3 
ACLcatl517 81.2 + 29.3 
ACLcat1375 99.5 +_ 31.0 
ACLcat 1081 88.6 + 4.18 
ACLcat861 89.5 _+ 18.4 
ACLcat537 105 +_ 26.8 
ACLcat194 88.7 + 31.0 
ACLcat 104 132 _+ 29.3 
ACLcat20 9.20 + 4.18 
pUC0cat 1.01 +_ 0.04 
The constructs of the ACL gene fused to the CAT gene were intro- 
duced into primary hepatocytes. These ACLcats have 3' endpoint at 
+ 128 and 5' endpoint at -2394 to -20. The hepatocytes were in- 
cubated with 0.1 M insulin and 20 mM glucose for 48 h after trans- 
fection, harvested and assayed for CAT activities. The percentages of
acetylated forms of [14C]chloramphenicol were determined as the 
CAT activities for each sample. The relative CAT activities of the 
deletion constructs are expressed as percentages of that of pUC2cat. 
Means_+ S.D. of 5-7 independent experiments are shown. 
insulin for 48 h, and then extracts were assayed for CAT 
activity. 
As shown in Table 2, the ACLcats having 3' endpoint at 
+128 and 5' endpoint  at -2394 to -104  exhibited similar 
CAT activities in the presence of glucose and insulin. How- 
ever, the CAT activities of ACLcat20 markedly decreased. 
Fig. 1 shows one of the typical results of autoradiograms 
for the CAT activities of ACLcat861, ACLcat194, ACLcat l04  
and ACLcat20. Insulin induced the activities of ACL- 
cats861,194,104 in the presence of glucose or pyruvate. The 
insulin-stimulation i  cells cultured with pyruvate were found 
to have a similar (or rather higher in ACLcat l04)  CAT activ- 
ity to the stimulation in cells grown with glucose. Thus, glu- 
cose was not necessarily required to the insulin activation of 
the CAT activities. In contrast o ACL, the other insulin-re- 
sponsive genes, such as L-type pyruvate kinase and S14 re- 
quired the presence of both insulin and glucose in cultured 
hepatocytes [19,20]. Thus, sequence elements located within 
-104  bp of the transcriptional start site are sufficient o con- 
fer insulin-stimulated expression. Further deletion to -20 ,  
however, resulted in loss of this response, indicating that se- 
quences responsible for insulin is located between -104  and 
-20  of ACL gene. 
The insulin stimulation of the CAT activities of ACL- 
cat861, ACLcat194 and ACLcat l04  was reduced in arachido- 
nic acid (20:4, n-6) treated cells, representing a 60% decline in 
ACL CAT activity. This suggests that arachidonic acid inhib- 
ited endogenous ACL gene expression at the transcriptional 
level (Fig. 1). The arachidonic acid-suppression of the insulin 
stimulation in the CAT activities roughly paralleled the sup- 
pression of ACL mRNA concentrations. However, as the in- 
sulin stimulation of the CAT activity of ACLcat l04  was very 
high (7-fold) in the presence of pyruvate, the stimulation was 
not completely suppressed by arachidonic acid. The upstream 
of --104 of ACL gene may have some sequences to disturb the 
insulin stimulation. 
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Fig. 1. The CAT activities of the constructs of ACL gene. The constructs of the ACL gene fused to the CAT gene (ACLcat861, 
ACLcatl04, ACLcat20) were introduced into primary hepatocytes. The hepatocytes were incubated with or without 0.1 /aM insulin 
ACLcat194, 
(Ins) for 48 
h in the presence of 20 mM pyruvate (Pyr) or glucose (Glu). When included, 0.1 mM arachidonic acid (20:4, n-6) was added. One of the typi- 
cal results is shown. The percentages of acetylated forms are normalized to the value for glucose+insulin in each ACLcat and shown as the re- 
lative CAT activities in parentheses. 
The insulin stimulation of the CAT activities of ACLcat 104 
was not reduced in stearic acid (18:0) or oleic acid (18:1) 
treated hepatocytes, but reduced in arachidonic acid treated 
cells. Similar effects were seen when eicosapentaenoic a id 
(20:5, n-3) or linoleic acid (18:2, n-6) was substituted for 
arachidonic acid (Fig. 2). Both n-3 and n-6 PUFA appeared 
to suppress the insulin activation of ACL  gene. Thus the 
region between -104  and -20  of the ACL gene is responsible 
for PUFA-repression as well as for insulin-stimulation of this 
gene. However, it is unknown if the responsive region of 
PUFA is different from that of insulin or not. Moreover, 
this does not necessarily mean that this region contains cis- 
acting element responsive to PUFA,  since PUFA may some- 
how inhibit the insulin signaling pathway from the insulin 
receptor to the ACL gene [21,22]. 
Table 3 shows comparison of nucleotide sequences of insu- 
lin- and PUFA-responsive region(s) of the ACL gene with 
those of other insulin-responsive genes such as FAS, ACC 
and GAPDH [3]. These regions have some sequence similarity 
between ucleotides -74  to -66  of the ACL gene and nucleo- 
tides -454  to -446  (7/9) and -462  to -454  (7/9) of the 
insulin-responsive r gion of GAPDH gene [3]. The nucleotides 
-87  to -79  of the ACL gene have some similarity to nucleo- 
tides -54  to -46  of the FAS gene (6/9). The nucleotides 161 
to -49  of the ACL gene have some sequence similarity, espe- 
cially between nucleotides -160  to -148 of the insulin re- 
sponsive region of ACC gene [23,24] (8/12 in -61  to --50 
and 8/11 in -60  to -50).  The similarity between nucleotides 
-60  to -49  of the ACL gene and nucleotides --54 to --43 of 
the FAS gene was 9 out of 12 and 8 out of 9 ( -51 to -43).  
Thus, the result suggests that the region of -61  to -49  of the 
ACL gene is insulin-responsive. However, significance of these 
similarity remains to be determined. The PUFA responsive 
element has been reported in the promoter region of the L- 
type pyruvate kinase L gene [5]. It has some similarity to the 
FAS gene (Fukuda, Iritani, Katsurada and Noguchi, unpub- 
lished data) but very little similarity to the ACL gene. 
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Fig. 2. Effect of fatty acid species on the CAT activities of the con- 
structs of ACL gene. The construct of the ACL gene fused to the 
CAT gene (ACLcatl04) was introduced into primary hepatocytes. 
The hepatocytes were incubated with 0.1 /aM insulin (Ins) and 20 
mM glucose (Glu) for 48 h, in addition of either 0.1 mM stearic 
acid (18:0), oleic acid (18:1), linoleic acid (18:2, n-6), arachidonic 
acid (20:4, n-6) or eicosapentaenoic acid (20:5, n-3). One of the ty- 
pical results is shown. The percentages of acetylated forms are nor- 
malized to the value for glucose+insulin a d shown as the relative 
CAT activities in parentheses. 
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Table 3 
Sequence comparison of postulated insulin- and PUFA-response le- 
ment(s) of ACL, FAS, ACC and GAPDH genes 
Sequence 
ACL ( -87 / -49)  5 ' -GCCAGGCTGCATGGCCTGTGAGCTGATGGGGGGCGGGGA-3 '  
***  **  * ****  * **  . * *******  
GCCGCGCGG GCCTCTCAG GCCGCGCGGGGA 
FAS GAPDH FAS 
( -54 / -46)  ( -462/~454)  ( -54 / -43)  
****  ***  *****  * **  
GCCTTTGAA TGGGGTCGGAGGT 
GAPDH 
( -454/ -446)  ****  ***  * 
TGGGGTCGGAGGT 
ACC 
( -160/ -148)  
*Similar to nucleotide of the ACL gene. 
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